- Monoamine Oxidase Inhibitors (MAO)
- Dopamine Precursors
- Catechol-o-methyltransferase Inhibitors (COMT)
- Peripheral Decarboxylase Inhibitors
- Others (Anticholinergics, Antihistaminics)
Parkinsons Treatment Market size was valued at USD 4,482.4 million in 2022, growing at a CAGR of 12.4% from 2023 to 2029. By drug class, the global parkinsons treatment market has been segmented into Monoamine Oxidase Inhibitors (MAO), Dopamine Precursors, Catechol-o-methyltransferase Inhibitors (COMT), Peripheral Decarboxylase Inhibitors, Others (Anticholinergics, Antihistaminics). The Peripheral Decarboxylase Inhibitors segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. It is attributed to the potency of the drug than other class of drugs. Based on distribution channel, the global parkinsons treatment market is segmented into Hospital Pharmacies, Online Pharmacies, Retail Pharmacies. Among these, the Hospital Pharmacies segment is expected to have the fastest-growing market during the forecast period 2023-2029 according to precision business insights. It is due to the large patient base in the hospital which makes high demand in hospital pharmacies. Also, the growing number of patient visits to the hospital due to the availability of diagnostic laboratories and skilled professionals and doctors. parkinsons disease is the chronic, progressive neurodegenerative disorder which can be characterized by rigidity, tremors, postural instability and bradykinesia (slowness of movement). In parkinsons disorder patients can also experience the significant non-motor symptoms like changes in the sleep disturbances, autonomic erectile dysfunction and cognition and mood swings. The condition is attributed to the degeneration of the dopamine-producing cells of the substantia nigra.
Fastest Growing Market
Growing advancements in the treatment is anticipated to propel the market growth over the forecast years. Moreover, the increasing geriatric population, increasing prevalence of Parkinson disease around the globe, treatment affordability are boosting the global market growth over the forecast years.
The fastest-growing segment of the global parkinson’s treatment market is Hospital pharmacies due to the growing number of patient visits to the hospital and availability of diagnostic laboratories.
New products and therapy launch especially research on gene therapy are trending in the global market which will further drive the market growth in the forecasted years.
The shift towards research activities from symptomatic treatment to Parkinson disorder modifying treatment will create lucrative growth in the global market.
Present of alternatives are the major restraining factors in the global market.